Found: 2

Select item for more details and to access through your institution.

  • Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.

    Published in:
    Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0275-4
    By:
    • Shusuke Yagi;
    • Yukina Hirata;
    • Takayuki Ise;
    • Kenya Kusunose;
    • Hirotsugu Yamada;
    • Daiju Fukuda;
    • Salim, Hotimah Masdan;
    • Gulinu Maimaituxun;
    • Susumu Nishio;
    • Yuriko Takagawa;
    • Saori Hama;
    • Tomomi Matsuura;
    • Koji Yamaguchi;
    • Takeshi Tobiume;
    • Takeshi Soeki;
    • Tetsuzo Wakatsuki;
    • Ken-ichi Aihara;
    • Masashi Akaike;
    • Michio Shimabukuro;
    • Masataka Sata
    Publication type:
    Article

  • Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

    Published in:
    2018
    By:
    • Yagi, Shusuke;
    • Aihara, Ken-ichi;
    • Kondo, Takeshi;
    • Kurahashi, Kiyoe;
    • Yoshida, Sumiko;
    • Endo, Itsuro;
    • Fukuda, Daiju;
    • Nakaya, Yutaka;
    • Suwaki, Kin-ichiro;
    • Takeji, Takashi;
    • Wada, Toshihiro;
    • Salim, Hotimah Masdan;
    • Hama, Saori;
    • Matsuura, Tomomi;
    • Ise, Takayuki;
    • Kusunose, Kenya;
    • Yamaguchi, Koji;
    • Tobiume, Takeshi;
    • Yamada, Hirotsugu;
    • Soeki, Takeshi
    Publication type:
    journal article